MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Mirum Pharmaceuticals, Inc. (MIRM)

Mirum Pharmaceuticals, Inc. (MIRM)

|||

Balance Sheets Overview

Current Ratio
285.61%
Quick Ratio
274.05%
Cash Ratio
148.45%
Debt to Asset Ratio
101.00%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Intangible assets, net
    • Accounts receivable
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Convertible notes payable, net, ...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
330,728
324,907
296,683
282,021
Short-term investments
107,563
61,352
86,644
93,527
Accounts receivable
145,360
133,113
123,330
107,132
Inventory
25,769
25,518
24,887
24,021
Prepaid expenses and other current assets
26,890
24,546
18,140
23,874
Total current assets
636,310
569,436
549,684
530,575
Restricted cash
1,734
1,733
1,482
480
Long-term investments
123,030
34,353
8,105
2,470
Property and equipment, net
2,251
2,412
1,862
1,277
Operating lease right-of-use assets
12,024
12,647
8,741
8,500
Intangible assets, net
247,388
254,154
260,921
231,895
Other assets
22,244
16,181
12,018
9,918
Total assets
1,044,981
890,916
842,813
785,115
Accounts payable
23,427
59,399
9,614
12,167
Holdback liabilities, current
24,800
25,800
-
-
Accrued expenses and other current liabilities
174,561
187,625
196,185
148,192
Total current liabilities
222,788
272,824
205,799
160,359
Operating lease liabilities, noncurrent
10,465
11,175
7,516
7,361
Convertible notes payable, net, noncurrent
750,079
310,251
309,797
309,368
Holdback liabilities, noncurrent
61,154
48,257
-
-
Other liabilities
10,917
5,915
5,011
15,981
Total liabilities
1,055,403
648,422
528,123
493,069
Common stock, 0.0001 par value 200,000,000 shares authorized 64,754,699 and 51,896,391 shares issued and outstanding as of june30, 2026 and december31, 2025, respectively
6
6
5
5
Additional paid-in capital
1,515,172
1,700,215
981,878
953,818
Accumulated deficit
-1,524,926
-1,457,699
-667,544
-661,814
Accumulated other comprehensive (loss) income
-674
-28
351
37
Total stockholders (deficit) equity
-10,422
242,494
314,690
292,046
Total liabilities and stockholders (deficit) equity
1,044,981
890,916
842,813
785,115
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$330,728K (44.98%↑ Y/Y)Accounts receivable$145,360K (36.06%↑ Y/Y)Short-term investments$107,563K (40.73%↑ Y/Y)Prepaid expenses andother current assets$26,890K (41.01%↑ Y/Y)Inventory$25,769K (12.33%↑ Y/Y)Total current assets$636,310K (40.34%↑ Y/Y)Intangible assets, net$247,388K (4.00%↑ Y/Y)Long-term investments$123,030K (618.97%↑ Y/Y)Other assets$22,244K (225.11%↑ Y/Y)Operating leaseright-of-use assets$12,024K (34.41%↑ Y/Y)Property and equipment,net$2,251K (91.25%↑ Y/Y)Restricted cash$1,734K (261.25%↑ Y/Y)Total assets$1,044,981K (43.97%↑ Y/Y)Accumulated deficit-$1,524,926K (-129.41%↓ Y/Y)Accumulated othercomprehensive (loss) income-$674K (-291.48%↓ Y/Y)Total liabilities andstockholders (deficit)...$1,044,981K (43.97%↑ Y/Y)Total stockholders(deficit) equity-$10,422K (-104.08%↓ Y/Y)Additional paid-in capital$1,515,172K (64.78%↑ Y/Y)Common stock, 0.0001par value...$6K (20.00%↑ Y/Y)Total liabilities$1,055,403K (124.24%↑ Y/Y)Convertible notes payable,net, noncurrent$750,079K (142.80%↑ Y/Y)Total currentliabilities$222,788K (53.86%↑ Y/Y)Holdback liabilities,noncurrent$61,154K Other liabilities$10,917K (20.58%↑ Y/Y)Operating leaseliabilities, noncurrent$10,465K (32.74%↑ Y/Y)Accrued expenses andother current...$174,561K (37.30%↑ Y/Y)Holdback liabilities,current$24,800K Accounts payable$23,427K (32.68%↑ Y/Y)